QT
TGTX icon

Quantbot Technologies’s TG Therapeutics TGTX Stock Holding History

Quantbot Technologies’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$679K Buy
12,363
+7,135
+136% +$292K 0.03% 791
2026
Q1 		$174K Sell
5,228
-3,549
-40% -$106K 0.01% 1211
2025
Q4 		$262K Buy
+8,777
New +$287K 0.01% 1161
2024
Q1 		– Sell
-365
Closed -$6.23K – 1943
2023
Q4 		$6.23K Buy
+365
New +$4.24K ﹤0.01% 1484
2023
Q2 		– Sell
-8,530
Closed -$128K – 1955
2023
Q1 		$128K Sell
8,530
-45,441
-84% -$690K 0.01% 1025
2022
Q4 		$638K Buy
53,971
+8,671
+19% +$62.9K 0.05% 498
2022
Q3 		$268K Sell
45,300
-49,690
-52% -$326K 0.02% 790
2022
Q2 		$403K Buy
+94,990
New +$593K 0.04% 661
2021
Q1 		– Sell
-1,706
Closed -$88K – 1754
2020
Q4 		$88K Buy
1,706
+705
+70% +$23.8K 0.01% 766
2020
Q3 		$26K Buy
1,001
+467
+87% +$10.7K ﹤0.01% 987
2020
Q2 		$10K Buy
534
+322
+152% +$5.19K ﹤0.01% 927
2020
Q1 		$2K Sell
212
-2,387
-92% -$30.1K ﹤0.01% 815
2019
Q4 		$28K Buy
+2,599
New +$19.8K ﹤0.01% 1023
2018
Q2 		– Sell
-3,822
Closed -$54K – 1489
2018
Q1 		$54K Buy
+3,822
New +$48.8K ﹤0.01% 962
2015
Q4 		– Sell
-19,882
Closed -$200K – 1359
2015
Q3 		$200K Buy
19,882
+14,982
+306% +$223K 0.03% 529
2015
Q2 		$81K Buy
4,900
+3,700
+308% +$58.6K 0.01% 706
2015
Q1 		$18K Sell
1,200
-5,348
-82% -$81K ﹤0.01% 913
2014
Q4 		$103K Buy
+6,548
New +$85.3K 0.03% 640

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Quantbot Technologies's TGTX Position: Q2 2026 in Review

Quantbot Technologies increased its TG Therapeutics (TGTX) stake by 136% in Q2 2026, buying an estimated $292K and bringing the position to 12,363 shares worth $679K. The position accounts for 0.03% of the portfolio, ranked #791.

Quantbot Technologies first reported a position in TGTX in Q4 2014 and has held it in 18 quarters since. 428 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Quantbot Technologies held 12,363 shares of TG Therapeutics worth $679K as of Q2 2026.
  • Quantbot Technologies bought 7,135 TG Therapeutics shares in Q2 2026, an estimated $292K.
  • TG Therapeutics made up 0.03% of Quantbot Technologies's portfolio in Q2 2026, its #791 holding.
  • Quantbot Technologies first reported a position in TG Therapeutics in Q4 2014 and has held it in 18 quarters since.
  • 428 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.